{"id":12,"date":"2024-11-18T11:46:19","date_gmt":"2024-11-18T11:46:19","guid":{"rendered":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/?page_id=12"},"modified":"2024-11-27T09:40:17","modified_gmt":"2024-11-27T09:40:17","slug":"person-specification","status":"publish","type":"page","link":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/person-specification\/","title":{"rendered":"Person Specification"},"content":{"rendered":"\n<section class=\"hero\">\n\t<div class=\"hero__container\">\n\t\t<div class=\"hero__row\">\n\t\t\t<div class=\"hero__image\">\n\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-content\/uploads\/sites\/367\/2024\/11\/bcuk-banner2.png\" alt=\"\" title=\"\" \/>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/section>\n\n\n\n<section class=\"title\">\n\t<div class=\"title__container\">\n\t\t<div class=\"title__row\">\n\t\t\t<div class=\"title__content\">\n\t\t<h1>\n\t\t  About the Major Appeal\t  <\/h1>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/section>\n\n\n\n<section class=\"content\">\n\t<div class=\"content__container\">\n\t\t<div class=\"content__row\">\n\t\t\t<div class=\"content__column\">\n\t\t  \t\t\t\t<p><strong>58% of all blood cancer deaths are caused by the hardest to treat cancers. <\/strong><\/p>\n<p>We believe it\u2019s possible to achieve significant shifts in survival, by making sure that all patients have access to the right treatment or drug at the right time.<\/p>\n<p><strong>That\u2019s why we need to launch a major appeal to raise \u00a325 million. <\/strong>This transformational investment in research, focussed across three programmes, will accelerate progress towards our goal of radical improvements in outcomes for these patients.<\/p>\n<p><strong>The \u00a325 million we raise will be split <\/strong><strong>across three \u00a38 million blood cancer research projects<\/strong> \u2013 <strong>including innovative clinical trials focused on blood cancer that have never been seen before in the UK.<\/strong> We\u2019ll also invest in vital services for patients, such as our Clinical Trials Support Service, helping to guide more patients towards the clinical trial that\u2019s right for them \u2013 whilst supporting them through the process.<\/p>\n<p><strong>\u00a325 million. 3 Groundbreaking research projects.<\/strong><\/p>\n<p>\u00a38m to study the least survivable myeloid cancers.<\/p>\n<p>\u00a38m to research myeloma.<\/p>\n<p>\u00a38m to target the hardest to treat lymphomas.<\/p>\n<p>\u00a31m for our Clinical Trials Support Service.<\/p>\n<p>&nbsp;<\/p>\n<h3><strong>Your impact <\/strong><\/h3>\n<p>It\u2019s an exciting time for blood cancer research, with significant breakthroughs ahead of us. Being part of the Board will have a huge impact, including:<\/p>\n<ul>\n<li>Funding 3 groundbreaking research projects for the hardest to treat blood cancers<\/li>\n<li>Discovering new drug combinations and therapies for patients who have run out of options<\/li>\n<li>Faster progress to discover new treatments by using adaptable, dynamic multi-arm, multi-stage studies in our clinical trials; moving, changing and developing treatments as trials progress<\/li>\n<li>Real-time impact for patients by giving access to new clinical trials and our Clinical Trials Support Service<\/li>\n<li>Widening the eligibility for clinical trials, so that more people, from all ages, stages and groups will be able to take part<\/li>\n<li>Creating change in NHS Practice for blood cancer patients<\/li>\n<li>Providing hope to blood cancer patients and increase the survival rates for the most deadly blood cancers.<\/li>\n<\/ul>\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-12","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/pages\/12","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/comments?post=12"}],"version-history":[{"count":7,"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/pages\/12\/revisions"}],"predecessor-version":[{"id":89,"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/pages\/12\/revisions\/89"}],"wp:attachment":[{"href":"https:\/\/micro.green-park.co.uk\/bloodcanceruk\/wp-json\/wp\/v2\/media?parent=12"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}